


The fund aims to provide income and some capital growth over the longer term by investing predominately in the shares of companies listed on European stock markets, excluding the UK.
| Name | % Net Assets |
|---|---|
| Sanofi | 3.2% |
| Swedish Match | 3.1% |
| Nestle | 2.9% |
| Zurich Insurance Group | 2.8% |
| Anheuser-Busch InBev NV | 2.8% |
| Wartsila B | 2.7% |
| Roche Holdings | 2.6% |
| Swiss Re Ltd | 2.5% |
| Unilever | 2.3% |
| ENI | 2.3% |
| Key | % Net Assets |
|---|---|
| 3.2% | |
| 3.1% | |
| 2.9% | |
| 2.8% | |
| 88% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 215.30p |
| Currency | GBP |
| Change | 0.80p |
| % | 0.37% |
| YTD change | 21.80p |
| YTD % | 11.27% |
| Fund Inception | 03/04/2009 |
|---|---|
| Fund Manager | n/a |
| TER | 1.61 (31-Dec-2010) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research